Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...

The company is betting that the alternative cytotoxic payload in its ADC can overcome resistance in patients who relapse on Enhertu.

Datroway is used to treat an advanced form of non-small cell lung cancer in adults who had received prior treatment.

Rise in geriatric population; increase in healthcare expenditure; and increase in investments in R&D activities by various healthcare companies.” — Allied Market Research PORTLAND, IN, UNITED STATES, ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

A mum who has breast cancer is one of thousands of women who could be "missing out" on life-extending drugs because of the way they are assessed by the health service, a charity has warned. Breast ...

Thousands of women with advanced breast cancer could be denied life-extending drugs because of the "unfair" way they are ...

With an FDA IND clearance, the firm will test IKS014 as an alternative for HER2-positive solid tumor patients in the US who have relapsed on other therapies.